Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agentsPaul S Humphries, Simon Bailey, Jonathon V Almaden, et al.BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.The American Journal of Medicine|April 13, 2017
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort StudySusan R Kahn, Arash Akaberi, John T Granton, et al.Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.The Annals of Pharmacotherapy|March 17, 2005
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs, Clive Kearon, Jim A Julian, et al.JAMA|January 1, 2008
Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trialDavid R Anderson, Susan R Kahn, Marc A Rodger, et al.Chest|December 10, 2016
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort StudySusan R Kahn, Andrew M Hirsch, Arash Akaberi, et al.Journal of Occupational and Environmental Medicine|July 9, 2021
Physical Activity Surveillance in the United States for Work and Commuting: Understanding the Impact on Population Health and Well-beingLaurie P Whitsel, Frederique Huneycutt, David R Anderson, et al.Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding modeMarvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.Pageof 15